Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on Septemb...(June 30 2009 and 2008 respective...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on September 8, 2009
Date:9/8/2009
June 30, 2009 and 2008, respectively 50 50 Common stock of $0.01 par value - authorized 150,000,000 shares; issued and outstanding 86,662,901 and 85,524,077 shares as of June 30, 2009 and 2008, respectively 866,629 855,241 Additional paid-in capital 209,712,379 208,247,194 Accumulated other comprehensive income 116,111 29,117 Accumulated deficit (207,381,670) (202,579,438) Total stockholders' equity 3,313,499 6,552,164 Total liabilities and stockholders' equity $13,199,811 $19,124,924
'/>"/>
| SOURCE Palatin Technologies, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
2. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
3. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
4. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
5. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
6. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
7. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
8. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
9. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
10. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
11. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008
Post Your Comments:
(Date:11/20/2009)...v. 20 Veridiam (www.veridiam.com) ...company category at the 2009 Workplace Excellence ...Society for Human Resources Management and recogni...tices. ,, Veridiam was one of nine winners, sel...ies, honored at the recent awards ceremony. San Di...
(Date:11/20/2009)...Nov. 20 Cell Therapeutic...ay that the Ninth Circuit Court of Appeals reverse...hould be allowed to pursue all of its claims again...strict Court for trial. CTI filed a complaint aga...bursement consultant for CTI,s product TRISENOX, i...
(Date:11/19/2009)...v. 19 Danish Prince Joachim inaugu...ol plant in Kalundborg, Denmark, on Wednesday, Nov... and largest 2nd generation ethanol demonstration ...used in the plant,s innovative process for convert..., was the first to market with commercial enzymes ...
(Date:11/19/2009).... 19 NeoStem, Inc. (NYSE...e following letter to its shareholders, discussing...f China Biopharmaceuticals Holdings, Inc. (CHBP), ...the People,s Republic of China. The merger gives N...harmaceutical Co. Ltd., CHBP,s primary operating s...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3[1] Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category[0] Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group[0] DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel[0] NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company
...can Oriental,Bioengineering, Inc. (NYSE: AOB ) to...ter 2008 financial results on Monday, August 11, 2...old a conference call at 5:00 pm ET on August 11,2...lts. Listeners may,access the call by dialing 1-80...lers, access code: 41757592. A webcast will also b...
...ent(R) Miniature Brachytherapy X-ray Source as One...oducts of the Past Year, SUNNYVALE, Calif., July ...High Dose Rate (HDR) X-ray Source has been selecte... one of the year,s most,technologically significan...zine in 1963, the R&D 100 Awards are designed to r...
... Cara Therapeutics, Inc.,announced today that it h...o its original $24 million Series C financing whic...investor, Devon Park Bioventures, and included,par...vestors participating,in the round included; Ascen...rporation and Wistar Morris. In conjunction with t...
Other Biology Technology:Xoft Recognized With R&D 100 Award 2Xoft Recognized With R&D 100 Award 3Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2(Date:11/22/2009)...to tobacco smoke and during childhood to lead face...esearch done at Cincinnati Children,s Hospital Med... percent of ADHD cases in children between the age... of these environmental exposures. This could tran...d lead exposure each have their own important adve...
(Date:11/22/2009)...ventoried an astonishing abundance, diversity and ...nown sunlight - creatures that somehow manage a li...(~3 miles) below the ocean waves. , Revealed vi...hnologies, animals known to thrive in an eternal w...tion of species ranging from crabs to shrimp to wo...
(Date:11/22/2009)...butterfly,s proboscis looks like a straw -- long, ... like a paper towel, according to Konstantin Korne...icks of this piece of insect anatomy to make small... , Kornev will present his work next week at the...ety,s (APS) Division of Fluid Dynamics will take p...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9Surrogacy and Egg Donation Seminar with Free Egg Donation Cycle 52453 1Surrogacy and Egg Donation Seminar with Free Egg Donation Cycle 52453 2Surrogacy and Egg Donation Seminar with Free Egg Donation Cycle 52453 3Surrogacy and Egg Donation Seminar with Free Egg Donation Cycle 52453 4Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 1Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 2Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 3Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 4Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 5Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 6Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 7my1HIE Fuels the Growth of E Prescribing in Michigan 52449 1my1HIE Fuels the Growth of E Prescribing in Michigan 52449 2my1HIE Fuels the Growth of E Prescribing in Michigan 52449 3my1HIE Fuels the Growth of E Prescribing in Michigan 52449 4my1HIE Fuels the Growth of E Prescribing in Michigan 52449 5my1HIE Fuels the Growth of E Prescribing in Michigan 52449 6...f the Nigerian government, the IAEA deployed a tea...t several potentially hazardous radioactive source...uel Cycle and Waste Technology department (NEFW) t...ria to safely recover the radiological sources and...anada or processing at a Nigerian waste facility. ...
...nia (Feb. 14, 2008) The small Pacific Island nati...ader by establishing the worlds largest marine pro...f pristine coral reefs and rich fish populations t...he Phoenix Islands Protected Area (PIPA) conserves...pelago ecosystems, consisting of eight coral atoll...
...aFor most northern indigenous people, the roughly ...rtant terrestrial subsistence resource, and while ...oncern about the on-going availability of caribou,...ffered. , For years people have managed natural...ems have functioned in the past, which assumes con...
Other Biology News:IAEA helps recover stray radioactive sources in Nigeria 2World's largest marine protected area created in Pacific Ocean 2World's largest marine protected area created in Pacific Ocean 3Seeking sustainability in a world of instability 2Power Supply for i-MyRun from Cosmo Bio Co., Ltd.
Orange G Loading Buffer from MBL International
Anti-YAP Polyclonal Antibody, Unconjugated from MBL International
Rabbit Anti-QKI Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |